Orlando、FLにおけるクローン病の臨床試験
Orlandoとその周辺地域（約30マイル以内）の拠点で、クローン病に関する17件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
被験者募集中第3相
- AdventHealth Orlando ( Site 5131), Orlando
- Endoscopic Research Inc ( Site 5061), Orlando
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
被験者募集中第2相
- Digestive And Liver Center Of Florida - Orlando /ID# 280924, Orlando
- Clinical Research of Osceola /ID# 280593, Kissimmee · 16マイル先
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
被験者募集中第4相
- Endoscopic Research, Inc., Orlando
- Orlando Health-Orlando Regional Medical Center, Orlando
- Digestive and Liver Center of Florida, P.A., Kissimmee · 16マイル先
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
被験者募集中第2相
- Endoscopic Research, Inc. /ID# 267211, Orlando
- Novum Research /ID# 278128, Clermont · 24マイル先
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
被験者募集中第2相
- AdventHealth (Florida Hospital) Medical Group, Orlando
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
被験者募集中第3相
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
被験者募集中第3相
- AdventHealth Orlando-Site Number: 8400070, Orlando
- Orlando Health, Inc.-Site Number: 8400084, Orlando
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee · 16マイル先
- 他1件
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
被験者募集中第3相
- Orlando Health, Inc., Digestive Health Institute-Site Number: 8400084, Orlando
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee · 16マイル先
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
被験者募集中第3相
- Arnold Palmer Hospital for Children Center Digestive Health and Nutrition-Orland /ID# 255437, Orlando
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
被験者募集中第2相
- Endoscopic Research Inc, Orlando
- Clinical Research of Osceola, Kissimmee · 16マイル先
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
被験者募集中第4相
- Endoscopic Research Inc, Orlando
- Clinical Research of Osceola, Kissimmee · 16マイル先
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
被験者募集中
- Advent Health, Orlando
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
被験者募集中観察研究
- AdventHealth, Orlando
Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD
被験者募集中第4相
- Digestive & Liver Center of Florida, Orlando
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
被験者募集中第2相
- Orlando Health, Inc., Orlando
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
被験者募集中第2相
- Investigational Site Number: 8400007, Orlando
- Investigational Site Number: 8400017, Kissimmee · 16マイル先
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
被験者募集中第2相
- Mirador Therapeutics Selected Site, Orlando
他の都市におけるクローン病の試験
- New York City, NY35件の研究
- Cleveland, OH19件の研究
- St. Louis, MO19件の研究
- Boston, MA19件の研究
- Miami, FL19件の研究
- Houston, TX17件の研究
- Atlanta, GA17件の研究
- Tyler, TX16件の研究
- San Diego, CA15件の研究
- San Antonio, TX15件の研究
- Los Angeles, CA15件の研究
- Philadelphia, PA13件の研究
Orlandoにおける他の研究
- 非小細胞肺癌44件の研究
- 肥満症31件の研究
- 転移性癌29件の研究
- 過体重27件の研究
- アルツハイマー病25件の研究
- 2型糖尿病24件の研究
- がん（全種類）24件の研究
- 乳がん23件の研究
- 卵巣がん22件の研究
- 潰瘍性大腸炎22件の研究
- 肺がん21件の研究
- 大腸癌19件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。